One day after a subcutaneous injection into ... In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of patients ...

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...

Following a 6-mg subcutaneous injection into the deltoid area of ... that Imitrex Injection may cause serious cardiovascular adverse reactions such as myocardial infarction or stroke, which ...

(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release ...

Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) granted approval for Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous ... in 10% of patients ...